12 pending office actions • 7 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §102 only | 1 (8%) |
| §112 only | 2 (17%) |
| Double-patenting + other | 3 (25%) |
| Multi-statute (no §101) | 5 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
| TAKENAKA, RISA | 1 | 28.6% | +100.0% |
| KNIGHT, TERESA E | 1 | 65.7% | +48.7% |
| PAULUS, ERIN VIRGINIA | 1 | 25.0% | +92.3% |
| VAN BUREN, LAUREN K | 1 | 39.5% | +58.0% |
| CHEN, STACY BROWN | 1 | 66.0% | +40.4% |
| LEITH, NANCY J | 1 | 74.7% | +43.8% |
| MONTANARI, DAVID A | 1 | 64.8% | +49.2% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038088 | DENSITY-ADJUSTED LIQUIDS AND METHODS USING SAME | VAN BUREN, LAUREN K | 66d overdue |
| 18559925 | METHODS FOR DELIVERING GENOME EDITING MOLECULES TO THE NUCLEUS OR CYTOSOL OF A CELL AND USES THEREOF | KNIGHT, TERESA E | 84d |
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — |
| 18718866 | COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES | CANDELARIA, JULIANA IRENE | — |
| 18709331 | METHODS TO GENERATE ENHANCED TUMOR INFILTRATING LYMPHOCYTES THROUGH MICROFLUIDIC DELIVERY | TAKENAKA, RISA | — |
| 18553292 | REPROGRAMMING OF CELLS AND USES THEREOF | PAULUS, ERIN VIRGINIA | — |
| 17425709 | ANUCLEATE CELL-DERIVED VACCINES | RIGA, MICHAEL ANGELO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038088 | DENSITY-ADJUSTED LIQUIDS AND METHODS USING SAME | VAN BUREN, LAUREN K | 66d overdue |
| 18318842 | DELIVERY OF BIOMOLECULES TO PBMCs TO MODIFY AN IMMUNE RESPONSE | CHEN, STACY BROWN | 1d overdue |
| 18559925 | METHODS FOR DELIVERING GENOME EDITING MOLECULES TO THE NUCLEUS OR CYTOSOL OF A CELL AND USES THEREOF | KNIGHT, TERESA E | 84d |
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — |
| 18709331 | METHODS TO GENERATE ENHANCED TUMOR INFILTRATING LYMPHOCYTES THROUGH MICROFLUIDIC DELIVERY | TAKENAKA, RISA | — |
| 18553292 | REPROGRAMMING OF CELLS AND USES THEREOF | PAULUS, ERIN VIRGINIA | — |
| 18190335 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL | LEITH, NANCY J | — |
| 18017512 | SYSTEMS AND METHODS FOR DIFFERENTIATING HEMATOPOIETIC CELLS | MONTANARI, DAVID A | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1638 | 2 |
| 1631 | 1 |
| 1672 | 1 |
| 1636 | 1 |
| 1632 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — | §102§103§112DP | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18718866 | COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES | CANDELARIA, JULIANA IRENE | — | §103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18709331 | METHODS TO GENERATE ENHANCED TUMOR INFILTRATING LYMPHOCYTES THROUGH MICROFLUIDIC DELIVERY | TAKENAKA, RISA | — | §102§112 | Non-Final OA | — | Pending | May 10, 2024 |
| 18559925 | METHODS FOR DELIVERING GENOME EDITING MOLECULES TO THE NUCLEUS OR CYTOSOL OF A CELL AND USES THEREOF | KNIGHT, TERESA E | 1634 | §102§112 | Non-Final OA | 84d | Pending | Nov 09, 2023 |
| 18553292 | REPROGRAMMING OF CELLS AND USES THEREOF | PAULUS, ERIN VIRGINIA | 1631 | §101§102§103§112 | Final Rejection | — | Pending | Sep 29, 2023 |
| 18038088 | DENSITY-ADJUSTED LIQUIDS AND METHODS USING SAME | VAN BUREN, LAUREN K | 1638 | §102§103§112 | Non-Final OA | 66d overdue | Pending | May 22, 2023 |
| 18318842 | DELIVERY OF BIOMOLECULES TO PBMCs TO MODIFY AN IMMUNE RESPONSE | CHEN, STACY BROWN | 1672 | §112 | Final Rejection | 1d overdue | Pending | May 17, 2023 |
| 18190335 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL | LEITH, NANCY J | 1636 | §112DP | Non-Final OA | — | Pending | Mar 27, 2023 |
| 18017512 | SYSTEMS AND METHODS FOR DIFFERENTIATING HEMATOPOIETIC CELLS | MONTANARI, DAVID A | 1632 | §102 | Final Rejection | — | Pending | Jan 23, 2023 |
| 17822942 | INTRACELLULAR DELIVERY OF COMPLEXES | VIVLEMORE, TRACY ANN | 1638 | §112 | Non-Final OA | — | Pending | Aug 29, 2022 |
| 17425709 | ANUCLEATE CELL-DERIVED VACCINES | RIGA, MICHAEL ANGELO | 1634 | §102§103§112Other | Non-Final OA | — | Pending | Jul 23, 2021 |
| 17282709 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION | JUEDES, AMY E | 1644 | §103§112DP | Final Rejection | — | Pending | Apr 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial